	US 12,290,519 B2
	Anti-inflammatory coupling compound drug, and preparation method therefor and use thereof
Lichun Feng, Shanghai (CN); Weijiang Zhang, Redwood City, CA (US); Guolong Wu, Shanghai (CN); Hao Zhang, Foster City, CA (US); and Dafeng Li, Shanghai (CN)
Assigned to COVAL BIOPHARMA (SHANGHAI) CO., LTD., Shanghai (CN)
Filed by COVAL BIOPHARMA (SHANGHAI) CO., LTD., Shanghai (CN)
Filed on Jan. 16, 2024, as Appl. No. 18/413,842.
Application 18/413,842 is a continuation of application No. PCT/CN2022/105503, filed on Jul. 13, 2022.
Claims priority of application No. 202110834326.4 (CN), filed on Jul. 20, 2021.
Prior Publication US 2024/0197741 A1, Jun. 20, 2024
Int. Cl. A61K 31/519 (2006.01); A61P 29/00 (2006.01)

CPC A61K 31/519 (2013.01) [A61P 29/00 (2018.01)]

4 Claims

1. An anti-inflammatory compound, or a stereoisomer, tautomer, nitrogen oxide, prodrug, pharmaceutically acceptable salt, or solvate thereof, wherein the compound is any one of the following specific compounds: